A5056663339- Cancer Research and Treatments
- Cancer, Hypoxia, and Metabolism
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- RNA modifications and cancer
- Immune Cell Function and Interaction
- SARS-CoV-2 and COVID-19 Research
- Cancer survivorship and care
- Long-Term Effects of COVID-19
- Cancer, Stress, Anesthesia, and Immune Response
- CAR-T cell therapy research
- Immune cells in cancer
- COVID-19 Clinical Research Studies
- IL-33, ST2, and ILC Pathways
- Cancer-related cognitive impairment studies
Centre de Recherche des Cordeliers
2021-2024
Université Paris Cité
2021-2024
Inserm
2021-2024
Sorbonne Université
2020-2024
Abstract One billion people worldwide get flu every year, including patients with non–small cell lung cancer (NSCLC). However, the impact of acute influenza A virus (IAV) infection on composition tumor microenvironment (TME) and clinical outcome NSCLC is largely unknown. We set out to understand how IAV load impacts growth modifies cellular molecular players in TME. Herein, we report that can infect both immune cells, resulting a long-term protumoral effect tumor-bearing mice....
SARS-CoV-2 infection leads to a highly variable clinical evolution, ranging from asymptomatic severe disease with acute respiratory distress syndrome, requiring intensive care units (ICU) admission. The optimal management of hospitalized patients has become worldwide concern and identification immune biomarkers predictive the outcome for remains major challenge. Immunophenotyping transcriptomic analysis COVID-19 at admission allow identifying two categories patients. Inflammation, high...
<p>Supplementary data file</p>
<div>Abstract<p>One billion people worldwide get flu every year, including patients with non–small cell lung cancer (NSCLC). However, the impact of acute influenza A virus (IAV) infection on composition tumor microenvironment (TME) and clinical outcome NSCLC is largely unknown. We set out to understand how IAV load impacts growth modifies cellular molecular players in TME. Herein, we report that can infect both immune cells, resulting a long-term protumoral effect tumor-bearing...
<div>Abstract<p>One billion people worldwide get flu every year, including patients with non–small cell lung cancer (NSCLC). However, the impact of acute influenza A virus (IAV) infection on composition tumor microenvironment (TME) and clinical outcome NSCLC is largely unknown. We set out to understand how IAV load impacts growth modifies cellular molecular players in TME. Herein, we report that can infect both immune cells, resulting a long-term protumoral effect tumor-bearing...
<p>Supplementary data file</p>
<p>Supplementary data file</p>
<p>Supplementary data file</p>
<div>Abstract<p>One billion people worldwide get flu every year, including patients with non–small cell lung cancer (NSCLC). However, the impact of acute influenza A virus (IAV) infection on composition tumor microenvironment (TME) and clinical outcome NSCLC is largely unknown. We set out to understand how IAV load impacts growth modifies cellular molecular players in TME. Herein, we report that can infect both immune cells, resulting a long-term protumoral effect tumor-bearing...